NAD+ 500mg
NAD+ 500mg – Research Grade Compound
Nicotinamide Adenine Dinucleotide (NAD+) is a naturally occurring coenzyme present in all living cells and is widely studied for its role in cellular energy metabolism, mitochondrial function, and biochemical signaling pathways. NAD+ continues to be included in ongoing laboratory and analytical research involving redox reactions, cellular energy transfer, and metabolic processes.
Supplied as a high-purity lyophilized (freeze-dried) powder, this research-grade compound is prepared under controlled handling conditions to support product stability, integrity, and long-term laboratory storage.
Each sealed sterile vial contains 500mg of high-purity NAD+ intended exclusively for scientific investigation and research applications.
Product Specifications
- Compound: Nicotinamide Adenine Dinucleotide (NAD+)
- Quantity: 500mg per vial
- Format: Lyophilized powder
- Purity: ≥98% purity verified through third-party testing
- Grade: Research use only
- Packaging: Sealed sterile research vial
Storage Recommendations
- Store refrigerated between 2–8°C for optimal long-term stability
- Protect from direct light, heat, and moisture
- Keep vial sealed until laboratory use
- Refrigeration recommended after reconstitution
- Avoid repeated freeze/thaw cycles
Research & Laboratory Applications
NAD+ continues to be utilized in ongoing investigational studies related to:
- mitochondrial function research
- cellular energy metabolism
- redox and biochemical signaling pathways
- metabolic and cellular process analysis
- laboratory analytical applications
Important Research Disclaimer
This product is intended strictly for laboratory research, analytical testing, and scientific investigation purposes only.
Not for human consumption.
Not for medical, therapeutic, veterinary, or diagnostic use.
By purchasing this product, the purchaser acknowledges that the material will only be handled within a lawful research environment by qualified professionals or researchers.



Reviews
There are no reviews yet.